Definitive Contract HHSD200201033942C

This is a definitive, firm fixed-price contract awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Novartis Vaccines and Diagnostics, Inc., a foreign-owned for-profit organization. The contract, valued at $3,998,636,358.75, is for the TAS 00HCVGBC-2010-82345 - Novartis Pediatric Vaccine Contract and does not have a set-aside designation. The contract has an ultimate completion date of March 31, 2011. As a pediatric vaccine contract, this award likely supports the CDC's vaccination programs and efforts to protect public health.